Outcome variables | Explanatory variables | Adjusted OR (95% CI) | P |
---|---|---|---|
TC ≥ 200 (mg/dl) | Antiretroviral therapy | 1.82 (1.06-3.12) | 0.02 |
Sex (Women vs. Men) | 0.83 (0.48-1.43) | 0.49 | |
Age > 40 years | 1.27 (0.74-2.17) | 0.39 | |
BMI > 25 kg/m2 | 1.05 (0.59-1.86) | 0.87 | |
Active tuberculosis | 0.49 (0.28-0.86) | 0.01 | |
CD4 count ≤ 200/mm3 | 2.56 (0.34-20.00) | 0.36 | |
LDL-c ≥ 130 (md/dl) | Antiretroviral therapy | 2.99 (1.74-5.15) | < 0.0001 |
Sex (Women vs. Men) | 1.06 (0.61-1.82) | 0.84 | |
Age > 40 years | 1.13 (0.66-1.94) | 0.65 | |
BMI > 25 kg/m2 | 1.87 (1.07-3.27) | 0.02 | |
Active tuberculosis | 0.54 (0.31-0.95) | 0.03 | |
CD4 count ≤ 200/mm3 | 1.92 (0.24-15.74) | 0.54 | |
TC/HDL-c ratio ≥ 5 | Antiretroviral therapy | 1.73 (1.04-2.89) | 0.03 |
Sex (Women vs. Men) | 1.88 (1.11-3.20) | 0.02 | |
Age > 40 years | 1.49 (0.89-2.50) | 0.20 | |
BMI > 25 kg/m2 | 0.68 (0.40-1.17) | 0.16 | |
Active tuberculosis | 1.12 (0.67-1.89) | 0.68 | |
CD4 count ≤ 200/mm3 | 1.78 (0.22-14.43) | 0.59 |